These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30968736)

  • 1. Target prioritization of novel substituted 5-aryl-2-oxo-/thioxo-2,3-dihydro-1
    Bhayye SS; Brahmachari G; Nayek N; Roy S; Roy K
    J Biomol Struct Dyn; 2020 Mar; 38(5):1415-1424. PubMed ID: 30968736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalyst-Free One-Pot Three-Component Synthesis of Diversely Substituted 5-Aryl-2-oxo-/thioxo-2,3-dihydro-1
    Brahmachari G; Nayek N
    ACS Omega; 2017 Aug; 2(8):5025-5035. PubMed ID: 31457779
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
    Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritization of bioactive compounds envisaging yohimbine as a multi targeted anticancer agent: insight from molecular docking and molecular dynamics simulation.
    Jabir NR; Rehman MT; AlAjmi MF; Ahmed BA; Tabrez S
    J Biomol Struct Dyn; 2023 Dec; 41(20):10463-10477. PubMed ID: 36533328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties.
    Choura E; Elghali F; Bernard PJ; Msalbi D; Marco-Contelles J; Aifa S; Ismaili L; Chabchoub F
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
    J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-pot synthesis of thiazolo[3,2-a]pyrimidine derivatives, their cytotoxic evaluation and molecular docking studies.
    Sekhar T; Thriveni P; Venkateswarlu A; Daveedu T; Peddanna K; Sainath SB
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Apr; 231():118056. PubMed ID: 32006911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
    Hameed R; Khan A; Khan S; Perveen S
    Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
    Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
    Paul M; Kumar Panda M; Thatoi H
    J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.
    Zhu W; Sun C; Xu S; Wu C; Wu J; Xu M; Zhao H; Chen L; Zeng W; Zheng P
    Bioorg Med Chem; 2014 Dec; 22(24):6746-54. PubMed ID: 25468038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tautomeric behaviour and isotopic multiplets in the 13C NMR spectra of partially deuterated 5-arylazo-pyrimidine (1H,3H,5H)-2,4,6-triones and 5-arylazo-2-thioxo-pyrimidine (1H,3H,5H)-4,6-diones-evidence for elucidation of tautomeric forms.
    Pesyan NN
    Magn Reson Chem; 2009 Nov; 47(11):953-8. PubMed ID: 19655369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic Liquid-Promoted Synthesis of Novel Chromone-Pyrimidine Coupled Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study and Toxicity Study.
    Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Karnik KS; Nikalje APG
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29462951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Biological Evaluation and Molecular Dynamics Simulation Studies of Novel Diphenyl Ethers.
    Khade AB; Kar SS; Alummoottil CT; Tiwari A; Tiwari M; Eshwara VK; Bhat P; Giliyar VB; Shenoy GG
    Med Chem; 2020; 16(2):256-270. PubMed ID: 30848207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6).
    Enayatkhani M; Salimi M; Azadmanesh K; Teimoori-Toolabi L
    J Biomol Struct Dyn; 2022 Jul; 40(10):4440-4450. PubMed ID: 33351722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation.
    Sobhy MK; Mowafy S; Lasheen DS; Farag NA; Abouzid KAM
    Bioorg Chem; 2019 Aug; 89():102988. PubMed ID: 31146197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as dual PI3Kα/mTOR inhibitors.
    Lei F; Sun C; Xu S; Wang Q; OuYang Y; Chen C; Xia H; Wang L; Zheng P; Zhu W
    Eur J Med Chem; 2016 Jun; 116():27-35. PubMed ID: 27043268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pyrazolopyrimidine derivatives with anticancer activity: Design, synthesis, PIM-1 inhibition, molecular docking study and molecular dynamics.
    Philoppes JN; Khedr MA; Hassan MHA; Kamel G; Lamie PF
    Bioorg Chem; 2020 Jul; 100():103944. PubMed ID: 32450389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.